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qRT-PCRAutism spectrum disorder (ASD) is a clinically complex and heterogeneous disorder. It is characterized by
impaired social abilities, disordered language, isolated areas of interest, and repetitive behaviors. Evidence sug-
gested that the neuropathology of ASD iswidely distributed, involving epigenetic regulation in the brain.MiRNAs
are a group of endogenous non-coding RNAs that play a critical role in neurodevelopment, neuroplasticity, and
other fundamental neurobiological processes. To study miRNA proﬁling in Autism spectrum disorder in China,
we performed miRNA microarray followed quantitative reverse transcription-polymerase chain reaction (qRT-
PCR). Here, we describe detailed methods and analysis on these microarray data which has been deposited in
Gene Expression Omnibus (GEO): GSE67979.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Direct link to deposited data
The deposited data can be found at: http://www.ncbi.nlm.nih.gov/
pubmed/?term=GSE67979.
2. Experimental design, materials and methods
2.1. Sample collection and RNA isolation
We totally recruited 20 patients and 20 controls. Peripheral blood
samples were obtained from patients and controls at Xiangya Hospital
[1]. Total RNAwasharvested by the TRIzol (Life Technologies) according
to the manufacturer's instructions [2]. The quality and quantity of RNA
were examined using an Agilent Bioanalyzer (Santa Clara) and K5500
micro-spectrophotometer (Kaiao). The total RNA was saved at−80 °C
until use.
2.2. miRNA expression proﬁling by microarray
RiboArray™ miDETECT™ Human Array microarrays (RIBOBIO),
which contained 2578 assay probes corresponding to the entire set of
primate miRNAs, were used to screen the miRNA expression.
Microarray was incubated 10 min in 65 °C followed by 1 h in 37 °C for. This is an open access article underprehybridization. 2.5 μg total RNA of each sample was labeled by Cy5.
The Cy5-labeled RNA samples could be readily visualized with compa-
rable intensity under UV. Labeling efﬁciency (1.0 to 3.6 was accepted
for good microarray result) can be calculated by the concentration of
CyDye and RNA measured by K5500 micro-spectrophotometer. Cy5-
labeled RNAwasdenaturated 3min in hybridization solution, incubated
20 s on ice, and hybridized to microarray 16 h in 37 °C. All microarrays
were successively washed by 6× SSPET, 3× SSPET, 0.5× SSPET, and
0.5× SSPET. Then, developer and coverslip were plus for scan (GenePix
4000B laser scanner), followed by bioinformatic analysis (digitized
using the R software). Fig. 1 showed part of the signal collection. Fig. 2
showed the log2 scale of the expression signal values that were plotted,
including control probes.
2.3. miRNA qRT-PCR analysis
Reverse transcription of total RNA to cDNAwas carried out in a 20 μL
reaction volume using RevertAid First Strand cDNA Synthesis Kit
(Fermentas) according to the manufacturer's instructions. Quantita-
tive PCR assays (CFX96, Bio-Rad) was carried out in a 20 μL reaction
volume containing 1 μL cDNA in the 15 autism patients and 15 health
controls. It was programmed for an initial denaturation step (95 °C,
3 min) followed by 40 ampliﬁcation cycles (95 °C, 10 s; 60 °C, 20 s).
The miRNA qRT-PCR primers were provided by RiboBio (Guangzhou,
China) [3]. Has-miR-16-5pwas used as an internal reference in the qRT-
PCR experiments [4,5]. Differences between control and experimental
samples were calculated using the 2−ΔΔCt method.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Part of the signal collection.
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We have studied miRNA proﬁling of ASD by using RiboArray™
miDETECT™ Human Array (A10101-1-12-19, 1×12K). Here, we
describe the detailed steps of the microarray analysis. Part of the signal
collection and box plot of raw data were provided. As a result, several
aberrantly expressed miRNAs related to ASD were discovered. This
study conﬁrmed that using miRNA array to study the easily accessible
peripheral blood is valid and repeatable [6–8].Fig 2. Box plot of raw data. Note: C1-5 means controls, A1-5 means patients.Conﬂict of interest
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